BOEHRINGER INGELHEIM ANIMAL HEALTH USA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at BOEHRINGER INGELHEIM ANIMAL HEALTH USA is $135,000, based on 34 certified filings from FY 2020 to FY 2026. This is 13% higher than the national H-1B median salary of $120,000. Compensation at BOEHRINGER INGELHEIM ANIMAL HEALTH USA reflects their market positioning, with entry-level roles starting around $107,000 and senior positions reaching $161,600 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at BOEHRINGER INGELHEIM ANIMAL HEALTH USA range from $80,000 at the 10th percentile to $161,600 at the 90th percentile, showing a $81,600 spread across experience levels and roles. The 25th percentile is $107,000 and the 75th percentile is $151,526.

Yes, BOEHRINGER INGELHEIM ANIMAL HEALTH USA actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), BOEHRINGER INGELHEIM ANIMAL HEALTH USA filed 11 H-1B labor condition applications with 11 certified and 0 denied, at a median salary of $143,252. Across FY 2020–2026, they have filed 36 total H-1B applications with 34 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. BOEHRINGER INGELHEIM ANIMAL HEALTH USA sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), BOEHRINGER INGELHEIM ANIMAL HEALTH USA filed 11 H-1B applications, with 11 certified and 0 denied. Over 6 years of data, BOEHRINGER INGELHEIM ANIMAL HEALTH USA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

BOEHRINGER INGELHEIM ANIMAL HEALTH USA's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 36 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating BOEHRINGER INGELHEIM ANIMAL HEALTH USA as a potential H-1B sponsor.

This is an excellent approval rate, indicating BOEHRINGER INGELHEIM ANIMAL HEALTH USA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

BOEHRINGER INGELHEIM ANIMAL HEALTH USA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 34 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles BOEHRINGER INGELHEIM ANIMAL HEALTH USA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at BOEHRINGER INGELHEIM ANIMAL HEALTH USA:

The most frequently sponsored role is Research Scientist with 7 filings at a median salary of $130,000. This is followed by Senior Research Scientist (6 filings) and Director, Late Stage Drug Product Development.

BOEHRINGER INGELHEIM ANIMAL HEALTH USA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where BOEHRINGER INGELHEIM ANIMAL HEALTH USA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top BOEHRINGER INGELHEIM ANIMAL HEALTH USA H-1B locations:

The largest H-1B hub for BOEHRINGER INGELHEIM ANIMAL HEALTH USA is Athens, GA with 10 filings at a median salary of $143,252. The highest-paying location is St. Joseph, MO at $150,000 median. Salaries range from $90,000 to $150,000 across office locations.

BOEHRINGER INGELHEIM ANIMAL HEALTH USA's median H-1B salary has increased by +8% from FY 2020 ($132,613) to FY 2026 ($143,252). Tracking salary trends over time reveals how BOEHRINGER INGELHEIM ANIMAL HEALTH USA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at BOEHRINGER INGELHEIM ANIMAL HEALTH USA.

Year-by-year breakdown:

• FY 2022: $220,000 (1 certified)
• FY 2023: $135,000 (4 certified)
• FY 2024: $115,800 (4 certified)
• FY 2025: $130,000 (11 certified)
• FY 2026: $143,252 (11 certified)

BOEHRINGER INGELHEIM ANIMAL HEALTH USA has maintained steady salary growth for H-1B positions over this period.

BOEHRINGER INGELHEIM ANIMAL HEALTH USA primarily files H-1B applications at Wage Level IV, accounting for 62% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making BOEHRINGER INGELHEIM ANIMAL HEALTH USA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 97% of positions at Level II or higher, BOEHRINGER INGELHEIM ANIMAL HEALTH USA typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

BOEHRINGER INGELHEIM ANIMAL HEALTH USA's median H-1B salary of $135,000 is 13% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating BOEHRINGER INGELHEIM ANIMAL HEALTH USA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare BOEHRINGER INGELHEIM ANIMAL HEALTH USA's offerings with similar companies in your field for a more accurate assessment.

BOEHRINGER INGELHEIM ANIMAL HEALTH USA offers above-average H-1B compensation. Combined with their 34 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. BOEHRINGER INGELHEIM ANIMAL HEALTH USA's higher proportion of Level III-IV positions (79%) may benefit from wage-based lottery prioritization.

With 34 certified filings, BOEHRINGER INGELHEIM ANIMAL HEALTH USA invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.